Healthcare provider profile · identity verified

Mark Philip Runde, M.D.

Internal Medicine · DUBUQUE, IA · NPI 1992759088

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	927	208
Amlodipine Besylate	Amlodipine Besylate	609	146
Furosemide	Furosemide	559	94
Omeprazole	Omeprazole	449	95
Levothyroxine Sodium	Levothyroxine Sodium	437	85
Simvastatin	Simvastatin	396	110
Losartan Potassium	Losartan Potassium	372	80
Potassium Chloride	Potassium Chloride	369	77
Metformin Hcl	Metformin Hcl	327	70
Metoprolol Tartrate	Metoprolol Tartrate	322	72
Tamsulosin Hcl	Tamsulosin Hcl	276	65
Gabapentin	Gabapentin	260	46
Metoprolol Succinate	Metoprolol Succinate	238	57
Lisinopril	Lisinopril	228	66
Hydrochlorothiazide	Hydrochlorothiazide	204	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	195	42
Allopurinol	Allopurinol	193	42
Pantoprazole Sodium	Pantoprazole Sodium	186	36
Clopidogrel	Clopidogrel Bisulfate	183	38
Atenolol	Atenolol	178	43
Prednisone	Prednisone	173	95
Mirtazapine	Mirtazapine	167	31
Xarelto	Rivaroxaban	167	23
Glimepiride	Glimepiride	165	35
Alprazolam	Alprazolam	159	33
Eliquis	Apixaban	159	23
Fluoxetine Hcl	Fluoxetine Hcl	154	27
Donepezil Hcl	Donepezil Hcl	139	22
Tramadol Hcl	Tramadol Hcl	139	50
Warfarin Sodium	Warfarin Sodium	131	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	124	36
Trazodone Hcl	Trazodone Hcl	122	23
Finasteride	Finasteride	114	27
Enalapril Maleate	Enalapril Maleate	110	24
Spironolactone	Spironolactone	105	21
Pravastatin Sodium	Pravastatin Sodium	103	19
Rosuvastatin Calcium	Rosuvastatin Calcium	101	29
Fluticasone Propionate	Fluticasone Propionate	95	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	86	20
Lorazepam	Lorazepam	86	17
Famotidine	Famotidine	85	11
Duloxetine Hcl	Duloxetine Hcl	81	16
Carvedilol	Carvedilol	78	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	76	53
Isosorbide Mononitrate Er	Isosorbide Mononitrate	70	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	21
Ropinirole Hcl	Ropinirole Hcl	68	13
Farxiga	Dapagliflozin Propanediol	67	suppressed
Jardiance	Empagliflozin	66	suppressed
Labetalol Hcl	Labetalol Hcl	64	suppressed
Sertraline Hcl	Sertraline Hcl	64	14
Methylprednisolone	Methylprednisolone	63	54
Amitriptyline Hcl	Amitriptyline Hcl	62	11
Chlorthalidone	Chlorthalidone	62	17
Escitalopram Oxalate	Escitalopram Oxalate	60	11
Glyburide	Glyburide	59	12
Azithromycin	Azithromycin	53	52
Memantine Hcl	Memantine Hcl	53	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	51	14
Ondansetron Hcl	Ondansetron Hcl	51	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	21
Albuterol Sulfate Hfa	Albuterol Sulfate	48	22
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	47	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Ventolin Hfa	Albuterol Sulfate	47	suppressed
Cephalexin	Cephalexin	46	28
Latanoprost	Latanoprost	46	suppressed
Ezetimibe	Ezetimibe	45	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	44	32
Minoxidil	Minoxidil	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Clonidine Hcl	Clonidine Hcl	43	suppressed
Ibuprofen	Ibuprofen	42	11
Metformin Hcl Er	Metformin Hcl	42	12
Entresto	Sacubitril/Valsartan	41	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	40	11
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Loperamide	Loperamide Hcl	39	17
Clonazepam	Clonazepam	38	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	16
Doxycycline Hyclate	Doxycycline Hyclate	36	27
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Digoxin	Digoxin	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Meloxicam	Meloxicam	35	suppressed
Nifedipine Er	Nifedipine	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	28
Hydrocortisone	Hydrocortisone	32	14
Levetiracetam	Levetiracetam	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Haloperidol	Haloperidol	28	suppressed
Nitroglycerin	Nitroglycerin	28	24
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Fluconazole	Fluconazole	27	14
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Lactulose	Lactulose	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	25	suppressed
Levofloxacin	Levofloxacin	25	23
Nystop	Nystatin	25	11
Glipizide Er	Glipizide	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Diazepam	Diazepam	23	suppressed
Flecainide Acetate	Flecainide Acetate	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	20	suppressed
Ozempic	Semaglutide	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	20	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	13
Nystatin	Nystatin	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Anastrozole	Anastrozole	16	suppressed
Cefuroxime	Cefuroxime Axetil	16	12
Montelukast Sodium	Montelukast Sodium	16	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	16	15
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Valsartan	Valsartan	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Glipizide	Glipizide	12	suppressed
Naproxen	Naproxen	12	suppressed
Tegretol Xr	Carbamazepine	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Colchicine	Colchicine	11	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error